Literature DB >> 33017191

SGLT2 inhibitors: diabetic kidney disease and beyond.

Alexander Staruschenko1,2, Vivek Bhalla3, Janani Rangaswami4,5.   

Abstract

Entities:  

Keywords:  Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation trial; Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease trial; kidney in cardiovascular disease; sodium-glucose cotransporter-2; sodium-glucose cotransporter-2 inhibitors

Mesh：

Substances：

Year:  2020        PMID： 33017191      PMCID： PMC7789985          DOI： 10.1152/ajprenal.00518.2020

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN： 1522-1466


× No keyword cloud information.
  9 in total

Review 1.  Development of SGLT1 and SGLT2 inhibitors.

Authors:  Timo Rieg; Volker Vallon
Journal:  Diabetologia       Date:  2018-08-22       Impact factor: 10.122

Review 2.  Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease.

Authors:  David León Jiménez; David Z I Cherney; Petter Bjornstad; Luis Castilla-Guerra; José Pablo Miramontes González
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-01

3.  Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.

Authors:  Bruce Neal; Vlado Perkovic; Kenneth W Mahaffey; Dick de Zeeuw; Greg Fulcher; Ngozi Erondu; Wayne Shaw; Gordon Law; Mehul Desai; David R Matthews
Journal:  N Engl J Med       Date:  2017-06-12       Impact factor: 91.245

4.  Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Authors:  Vlado Perkovic; Meg J Jardine; Bruce Neal; Severine Bompoint; Hiddo J L Heerspink; David M Charytan; Robert Edwards; Rajiv Agarwal; George Bakris; Scott Bull; Christopher P Cannon; George Capuano; Pei-Ling Chu; Dick de Zeeuw; Tom Greene; Adeera Levin; Carol Pollock; David C Wheeler; Yshai Yavin; Hong Zhang; Bernard Zinman; Gary Meininger; Barry M Brenner; Kenneth W Mahaffey
Journal:  N Engl J Med       Date:  2019-04-14       Impact factor: 91.245

5.  Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart Association.

Authors:  Janani Rangaswami; Vivek Bhalla; Ian H de Boer; Alexander Staruschenko; Johanna A Sharp; Radhika Rajgopal Singh; Kevin Bryan Lo; Katherine Tuttle; Muthiah Vaduganathan; Hector Ventura; Peter A McCullough
Journal:  Circulation       Date:  2020-09-28       Impact factor: 29.690

Review 6.  The tubular hypothesis of nephron filtration and diabetic kidney disease.

Authors:  Volker Vallon; Scott C Thomson
Journal:  Nat Rev Nephrol       Date:  2020-03-09       Impact factor: 28.314

7.  Dapagliflozin in Patients with Chronic Kidney Disease.

Authors:  Hiddo J L Heerspink; Bergur V Stefánsson; Ricardo Correa-Rotter; Glenn M Chertow; Tom Greene; Fan-Fan Hou; Johannes F E Mann; John J V McMurray; Magnus Lindberg; Peter Rossing; C David Sjöström; Roberto D Toto; Anna-Maria Langkilde; David C Wheeler
Journal:  N Engl J Med       Date:  2020-09-24       Impact factor: 91.245

8.  Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.

Authors:  George L Bakris; Rajiv Agarwal; Stefan D Anker; Bertram Pitt; Luis M Ruilope; Christina Nowack; Peter Kolkhof; Anna C Ferreira; Patrick Schloemer; Gerasimos Filippatos
Journal:  Am J Nephrol       Date:  2019-10-25       Impact factor: 3.754

9.  Advancing Nephrology: Division Leaders Advise ASN.

Authors:  Gregory L Braden; Arlene Chapman; David H Ellison; Crystal A Gadegbeku; Susan B Gurley; Peter Igarashi; Ellie Kelepouris; Marva M Moxey-Mims; Mark D Okusa; Troy J Plumb; Susan E Quaggin; David J Salant; Mark S Segal; Stuart J Shankland; Stefan Somlo
Journal:  Clin J Am Soc Nephrol       Date:  2020-08-12       Impact factor: 8.237
  9 in total
  2 in total

1.  SGLT2 inhibition effect on salt-induced hypertension, RAAS, and Na+ transport in Dahl SS rats.

Authors:  Olha Kravtsova; Ruslan Bohovyk; Vladislav Levchenko; Oleg Palygin; Christine A Klemens; Timo Rieg; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2022-04-25

2.  Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility.

Authors:  Glen James; Juan Jose Garcia Sanchez; Juan Jesus Carrero; Supriya Kumar; Roberto Pecoits-Filho; Hiddo J L Heerspink; Stephen Nolan; Carolyn S P Lam; Hungta Chen; Eiichiro Kanda; Naoki Kashihara; Matthew Arnold; Mikhail N Kosiborod; Mitja Lainscak; Carol Pollock; David C Wheeler
Journal:  Kidney Int Rep       Date:  2022-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.